Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Protection of Ovarian Function With Goserelin Acetate in Premenopausal Early Breast Cancer Patients Undergoing Adjuvant Chemotherapy: An Open Label, Randomised, Multi-Centre, Phase IIIb Study

NCT00888082 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00888082
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00888082 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Protection of Ovarian Function With Goserelin Acetate in Premenopausal Early Breast Cancer Patients Undergoing Adjuvant Chemotherapy: An Open Label, Randomised, Multi-Centre, Phase IIIb Study
Lead sponsor
AstraZeneca
Phase
Phase 3
Overall status
Withdrawn
Start date
Not reported
Completion date
April 30, 2012
Enrollment
102 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, ovarian function